Workflow
万红软膏
icon
Search documents
达仁堂(600329):2025H1内生利润表现亮眼 提质增效步入新阶段
Xin Lang Cai Jing· 2025-08-18 06:25
Core Viewpoint - The company reported its 2025 mid-year results, showing a significant decline in revenue but a substantial increase in net profit, primarily due to strategic divestitures and core product performance [1][2][3]. Financial Performance - In H1 2025, the company achieved revenue of 2.651 billion yuan, a year-over-year decrease of 33.15%. The net profit attributable to shareholders was 1.928 billion yuan, reflecting a year-over-year increase of 193.08%. The non-recurring net profit was 596 million yuan, down 5.93% year-over-year [1][2]. - For Q2 2025, the company reported revenue of 1.195 billion yuan, a decline of 36.40% year-over-year, while the net profit attributable to shareholders surged to 1.553 billion yuan, up 474.49% year-over-year. The non-recurring net profit for Q2 was 221 million yuan, down 14.51% year-over-year [1][2]. Business Segments - The industrial segment showed stable performance with a 13% growth in internal profits. The main revenue from industrial operations was 2.645 billion yuan, a slight increase of 0.87% year-over-year [2]. - The increase in net profit was largely due to the transfer of a 12% stake in a subsidiary, generating a post-tax net gain of 1.308 billion yuan. The decrease in non-recurring net profit was attributed to the sale of a 25% stake in an associate company, which previously contributed 106 million yuan in investment income [2]. Operational Efficiency - The company’s gross margin improved to 74.67%, an increase of 24.74 percentage points year-over-year, mainly due to structural optimization following the divestiture of its commercial operations [3]. - The company reduced sales, management, and R&D expenses by 1.00%, 21.44%, and increased R&D expenses by 31.94%, respectively [3]. Product Performance - The company focused on its core product, the "Suxiao Jiuxin Wan," which generated sales of 1.128 billion yuan, up 5.45% year-over-year. The "Qingyan Diban" product achieved sales of 289 million yuan, a significant increase of 52.28% year-over-year [3]. - The company has made strides in international registrations, obtaining nine international product registration certificates during the reporting period [3]. Future Outlook - The company is expected to achieve revenues of 4.89 billion yuan, 5.39 billion yuan, and 5.863 billion yuan for 2025-2027, with year-over-year changes of -33%, +10%, and +9%, respectively. The net profit attributable to shareholders is projected to be 2.162 billion yuan, 985 million yuan, and 1.029 billion yuan, with corresponding year-over-year changes of -3%, -54%, and +4% [3].